Emerging Disease News and Research

RSS
Infinity commences enrollment in IPI-493 Phase 1 clinical trial for advanced hematologic malignancies

Infinity commences enrollment in IPI-493 Phase 1 clinical trial for advanced hematologic malignancies

Infinity announces Phase 2 clinical trial results of IPI-504 for NSCLC

Infinity announces Phase 2 clinical trial results of IPI-504 for NSCLC

Infinity to present data from Hsp90 chaperone and Hedgehog pathway inhibitor programs at 2010 ASCO

Infinity to present data from Hsp90 chaperone and Hedgehog pathway inhibitor programs at 2010 ASCO

Ecological speciation linked to emergence of new fungal diseases in plants

Ecological speciation linked to emergence of new fungal diseases in plants

Infinity Pharmaceuticals initiates Phase 1b/2 trial of IPI-926 Hedgehog pathway inhibitor for pancreatic cancer

Infinity Pharmaceuticals initiates Phase 1b/2 trial of IPI-926 Hedgehog pathway inhibitor for pancreatic cancer

Vical awarded contract to conduct Phase 1 clinical trial of Vaxfectin-formulated DNA vaccine against A/H1N1

Vical awarded contract to conduct Phase 1 clinical trial of Vaxfectin-formulated DNA vaccine against A/H1N1

PPD, Southern Research Institute collaborate in pandemic and seasonal influenza vaccine research

PPD, Southern Research Institute collaborate in pandemic and seasonal influenza vaccine research

Data from novel Hedgehog pathway inhibitor program to be presented at upcoming conferences

Data from novel Hedgehog pathway inhibitor program to be presented at upcoming conferences

Novel interventions for New World hemorrhagic fevers needed

Novel interventions for New World hemorrhagic fevers needed

Hebrew University of Jerusalem receives $5 million grant from Bill & Melinda Gates Foundation

Hebrew University of Jerusalem receives $5 million grant from Bill & Melinda Gates Foundation

La Jolla Institute for Allergy & Immunology awarded $18.8M NIH grant for infectious diseases study

La Jolla Institute for Allergy & Immunology awarded $18.8M NIH grant for infectious diseases study

Hebrew University of Jerusalem granted $5M for research into visceral leishmaniasis in Ethiopia

Hebrew University of Jerusalem granted $5M for research into visceral leishmaniasis in Ethiopia

UK research funders announce support for a series of H1N1 2009 research projects

UK research funders announce support for a series of H1N1 2009 research projects

Tufts University receives $185M grant as part of the USAID Emerging Pandemic Threats program

Tufts University receives $185M grant as part of the USAID Emerging Pandemic Threats program

Five-year program aimed at preventing future pandemic diseases awarded to DAI

Five-year program aimed at preventing future pandemic diseases awarded to DAI

Wildlife Conservation Society to monitor diseases for preventing global pandemic

Wildlife Conservation Society to monitor diseases for preventing global pandemic

UC Davis' international effort to prevent new pandemics

UC Davis' international effort to prevent new pandemics

UT Southwestern Medical Center awarded $15.7M NIH contract to develop a new virus database

UT Southwestern Medical Center awarded $15.7M NIH contract to develop a new virus database

Australian scientist finds two new animal viruses

Australian scientist finds two new animal viruses

Economic recession, emerging diseases should not replace efforts to fight HIV/AIDS, IAS President says

Economic recession, emerging diseases should not replace efforts to fight HIV/AIDS, IAS President says